Laman UtamaSLP • NASDAQ
add
Simulations Plus Inc
Tutup sebelumnya
$12.99
Julat hari
$12.62 - $15.56
Julat tahun
$11.09 - $36.45
Permodalan pasaran
262.71J USD
Bilangan Purata
231.47K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Feb 2026info | Perubahan T/T |
|---|---|---|
Hasil | 24.29J | 8.29% |
Perbelanjaan pengendalian | 10.51J | -0.02% |
Pendapatan bersih | 4.54J | 47.53% |
Margin untung bersih | 18.67 | 36.28% |
Pendapatan bagi setiap syer | 0.35 | 12.90% |
EBITDA | 6.28J | 53.60% |
Kadar cukai berkesan | 22.95% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Feb 2026info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 41.84J | 95.63% |
Jumlah aset | 146.48J | -27.28% |
Jumlah liabiliti | 12.71J | 7.02% |
Jumlah ekuiti | 133.77J | — |
Syer tertunggak | 20.14J | — |
Harga kepada buku | 1.96 | — |
Pulangan pada aset | 9.90% | — |
Pulangan pada modal | 10.75% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Feb 2026info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 4.54J | 47.53% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. Wikipedia
Diasaskan
1996
Ibu pejabat
Tapak web
Pekerja
213
